Sushmi Dey ...

A promising path to fighting COVID and other coronaviruses may have been based on a serious mistake. Scientists had zeroed in ...

Scientists have uncovered a stealthy tactic used by the SARS-CoV-2 virus: one of its proteins can leap from infected cells to ...

The WHO Scientific Advisory Group for the Origins of Novel Pathogens (SAGO), a panel of 27 independent, international, ...

Since the emergence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), understanding the mechanisms underlying ...

In fact, the team, with drug development expertise of Wyss Senior Principal Scientist Sylvie Bernier, Ph.D., and Wyss’ Senior Director, Translational R&D, Ken Carlson, Ph.D., demonstrated that ...

SARS-CoV-2 articles from across Nature Portfolio SARS-CoV-2 is a positive-sense single-stranded RNA virus. It is contagious in humans and is the cause of the coronavirus disease 2019 (COVID-19).

Photo: Bristol-Myers Squibb Co. Shares of BioNTech SE were soaring in early Monday trading, after Bristol Myers Squibb Co. made an $11.1 billion splash in the rapidly growing new cancer-drug game.

U.S. aid cuts could jeopardize the supply of donated drugs that are hailed for their effectiveness in combating neglected diseases like river blindness, schistosomiasis and trachoma.

Health and Human Services Secretary Robert F. Kennedy Jr. said on Thursday that the U.S. drugs regulator would look for ways to fast-track approval for rare disease treatments and remove obstacles ...

Otsuka Pharmaceutical has shared more detailed data behind its kidney disease drug’s phase 3 win, showing the monoclonal antibody halved patients’ urine protein-to-creatinine ratio (UPCR) levels.